Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Perinatol ; 32(13): 1247-50, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26023907

RESUMEN

OBJECTIVE: The purpose of our study was to determine whether the current antibiotic regimen for preterm premature rupture of membranes (PPROM) is adequate for covering the current causative agents and sensitivities of chorioamnionitis and early-onset neonatal sepsis. STUDY DESIGN: During a 3-year period, we retrieved the results from placental and amniotic membrane cultures obtained at delivery in cases of maternal fever, chorioamnionitis, and PPROM, and from blood cultures obtained from neonates with early-onset sepsis (EOS) in three participating hospitals. Sensitivity of pathogens to antimicrobial agents was performed using routine microbiologic techniques. RESULTS: There were 1,133 positive placental or amniotic cultures, 740 (65.3%) were from gram-negative Enterobacteriaceae. There were 27 neonates diagnosed with EOS with positive blood cultures. Aerobic Enterobacteriaceae accounted for 14 cases (52%) and group B streptococcus for 7 cases (26%). Of the Escherichia coli and Klebsiella sp., only 38% were sensitive to ampicillin. CONCLUSION: Local pathogens and their antibiotic sensitivity profiles should be explored every few years and an effective antibiotic protocol chosen to cover the main pathogens causing chorioamnionitis and EOS. Consideration should be made for changing ampicillin in women with PPROM to a regimen with better coverage of gram-negative Enterobacteriaceae.


Asunto(s)
Antibacterianos/uso terapéutico , Corioamnionitis/prevención & control , Rotura Prematura de Membranas Fetales/tratamiento farmacológico , Enfermedades del Recién Nacido/prevención & control , Sepsis/prevención & control , Amnios/microbiología , Amoxicilina/uso terapéutico , Ampicilina/uso terapéutico , Corioamnionitis/microbiología , Clindamicina/uso terapéutico , Protocolos Clínicos , Farmacorresistencia Bacteriana , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/prevención & control , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Femenino , Gentamicinas/uso terapéutico , Humanos , Recién Nacido , Enfermedades del Recién Nacido/microbiología , Infecciones por Klebsiella/microbiología , Infecciones por Klebsiella/prevención & control , Pruebas de Sensibilidad Microbiana , Placenta/microbiología , Embarazo , Estudios Retrospectivos , Roxitromicina/uso terapéutico , Sepsis/microbiología , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/prevención & control , Streptococcus agalactiae
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA